Investor narrative · Pitch strategy

From Science
to Series A.

We help biotech founders translate science into investor conviction — and funding.

When communication isn’t tailored, funding slips.

Decks written for scientists may overwhelm investor audiences. Scientific milestones do not automatically translate into investor returns, and opportunistic story evolution can erode conviction and credibility.

Lower valuation

Confusion is priced in.

Investors discount risk they cannot quantify.

More meetings

More pitching, fewer deals.

More rounds of pitching, fewer term sheets. Your runway burns.

Investors lost

Conviction has to build fast.

Investors walk when the narrative does not make the opportunity clear enough.

The rare intersection of science, business and storytelling.

BioNarrative works at the point where deep biotech understanding meets investor logic and communication craft.

01 · Communication expertise

Narratives that build investor conviction.

Not just slides. Every word earns its place in your story.

02 · Business understanding

We think like investors.

Market sizing, competitive positioning and exit scenarios — in the language investors use.

03 · Biotech insight

Science translated, not diluted.

We understand the science and industry to position your innovation.

Your investor-ready story, built from the ground up.

We build a clearer and compelling equity story increasing the probability of convincing investors.

→

Investor-ready narrative

A clear, compelling equity story built around your science.

→

Pitch deck + story arc

Slides that balance data with conviction-building narrative.

→

Messaging framework

Consistent language for every investor touchpoint.

→

Founder training

Coaching so you can deliver your story with confidence.

A close partnership built around your timeline.

A five-week working approach that moves from scientific and market evidence to a polished, investor-ready narrative.

Week 1

Data Review

Deep dive into your science, pipeline and competitive landscape. We extract the investable signal.

Week 2

Narrative Build

Craft your equity story, positioning and core messaging. Align on voice and tone.

Weeks 3–4

Deck + Iteration

Build pitch deck and materials with multiple rounds of feedback and refinement.

Week 5

Investor-Ready

Final polish, Q&A prep and materials delivered. You walk in ready to close.

A complete investor-ready package.

Core fundraising materials designed to work together as one consistent investor narrative.

10–15 slides

Pitch Deck

1 page

Outreach One-Pager

2 pages

Executive Summary

Messaging reference

Narrative Guide

Investor prep

Q&A Preparation

Close the gap between what investors hear and what you mean.

We identify where investors may misread the company — then reframe the story around de-risking, value creation and competitive advantage.

“Your timeline is too long.”
→Milestones become de-risking events that increase asset value.
“The science is the risk.”
→Your approach is positioned as the unfair advantage.
“We don’t see the market size.”
→A bottom-up narrative connects technology to market opportunity.
“Can this team deliver?”
→Your expertise becomes part of the competitive moat.

The people behind your pitch.

Experience across global biopharma, life-science advisory, company building, commercial strategy and fundraising.

Gert Vium Andersen

Investor Narrative & Positioning

Gert helps founders and management teams translate complex science into clear, investable narratives, with focus on asset positioning, market opportunity and investor messaging.

Rasmus Drewes Jensen

Commercial, Operations & Financial Strategy

Rasmus helps turn promising science into companies that can be financed, operationalised and built to last, spanning financial modelling, market entry, licensing, partnering and fundraising.

Let’s prepare your equity story.

A compelling investor-ready narrative from slide one — designed for clearer positioning, stronger conviction and more effective fundraising conversations.